| Literature DB >> 26889774 |
Yaofeng Cheng1, Ayman El-Kattan2, Yan Zhang3, Adrian S Ray4, Yurong Lai1.
Abstract
Membrane transporters play a pivotal role in many organs to maintain their normal physiological functions and contribute significantly to drug absorption, distribution, and elimination. Knowledge gained from gene modified animal models or human genetic disorders has demonstrated that interruption of the transporter activity can lead to debilitating diseases or organ toxicities. Herein we describe transporter associated diseases and organ toxicities resulting from transporter gene deficiency or functional inhibition in the liver, kidney, gastrointestinal tract (GIT), and central nervous system (CNS). While proposing additional transporters as targets for drug-induced organ toxicity, strategies and future perspectives are discussed for transporter risk assessment in drug discovery and development.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26889774 DOI: 10.1021/acs.chemrestox.5b00511
Source DB: PubMed Journal: Chem Res Toxicol ISSN: 0893-228X Impact factor: 3.739